Fast Track Initiative
Tokyofti-jp.com
Overview
Fast Track Initiative is a life science venture capital firm that invests in early-stage startups with a focus on biotechnology, therapeutics, and healthcare innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neusignal Therapeutics, Inc. | Jun 2026 | Series B | Co-investor |
| STORM Therapeutics | Apr 2026 | Series C | Co-investor |
| SONIRE Therapeutics Inc. | Apr 2026 | Series A | Co-investor |
| Metagen Therapeutics, Inc. | Feb 2026 | Series B | Co-investor |
| QualiHQ | Feb 2026 | Series A | Lead |
Key People
Natalie Roy D'Amore
Venture Partner
Yukihiko Ebisuno
Venture Partner
Tai Harada
Partner
Tomohiro Anzai
COO And Managing Partner
Hiroko Kimura
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
